Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients? | Zendy

Raghid Kreidy | Zendy; Noha IraniHakime | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?

Author(s) -

Raghid Kreidy,

Noha IraniHakime

Publication year - 2009

Publication title -

vascular health and risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.892

H-Index - 68

eISSN - 1178-2048

pISSN - 1176-6344

DOI - 10.2147/vhrm.s6184

Subject(s) - medicine , thrombophilia , factor v leiden , thrombosis , deep vein , methylenetetrahydrofolate reductase , risk factor , venous thrombosis , factor v , surgery , prothrombin g20210a , population , pediatrics , genotype , environmental health , biochemistry , chemistry , gene

Factor V Leiden (R506Q) mutation is the most commonly observed inherited genetic abnormality related to vein thrombosis. Lebanon has one of the highest frequencies of this mutation in the world with a prevalence of 14.4% in the general population. The aim of this study is to define risk factors including inherited genetic abnormalities among Lebanese patients with lower extremity deep vein thrombosis. We report the clinical outcome of patients with thrombophilia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research